UniSa - IRIS Institutional Research Information System

SELLERI, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.894
AS - Asia 17.368
EU - Europa 5.636
SA - Sud America 908
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 15
Totale 42.947
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.740
HK - Hong Kong 13.132
CN - Cina 1.401
SG - Singapore 1.377
UA - Ucraina 1.192
IT - Italia 1.070
DE - Germania 988
BR - Brasile 784
RU - Federazione Russa 740
VN - Vietnam 556
FI - Finlandia 482
IE - Irlanda 429
KR - Corea 314
TR - Turchia 276
SE - Svezia 184
ES - Italia 148
AT - Austria 107
GB - Regno Unito 107
IN - India 107
CA - Canada 83
JP - Giappone 52
AR - Argentina 44
CZ - Repubblica Ceca 42
MX - Messico 35
NL - Olanda 30
BD - Bangladesh 29
PL - Polonia 29
EC - Ecuador 28
EU - Europa 28
ZA - Sudafrica 26
ET - Etiopia 23
FR - Francia 19
ID - Indonesia 18
PK - Pakistan 15
VE - Venezuela 13
UZ - Uzbekistan 12
IQ - Iraq 11
LT - Lituania 11
PE - Perù 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
AU - Australia 9
KE - Kenya 8
MA - Marocco 8
CH - Svizzera 7
CO - Colombia 7
EG - Egitto 7
KG - Kirghizistan 7
PY - Paraguay 7
CL - Cile 6
DO - Repubblica Dominicana 6
NZ - Nuova Zelanda 6
DZ - Algeria 5
HN - Honduras 5
HU - Ungheria 5
PS - Palestinian Territory 5
SA - Arabia Saudita 5
BZ - Belize 4
CR - Costa Rica 4
HR - Croazia 4
LU - Lussemburgo 4
LV - Lettonia 4
MK - Macedonia 4
MY - Malesia 4
TN - Tunisia 4
UY - Uruguay 4
BB - Barbados 3
BE - Belgio 3
BG - Bulgaria 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
IR - Iran 3
MD - Moldavia 3
NG - Nigeria 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LY - Libia 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
TJ - Tagikistan 2
TZ - Tanzania 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
Totale 42.924
Salva come PNG Salva come JPEG
Città #
Hong Kong 13.111
Ann Arbor 4.703
Woodbridge 2.446
Jacksonville 1.460
Chandler 1.347
Houston 1.164
Princeton 1.164
Wilmington 1.110
Dallas 1.102
Ashburn 573
Singapore 534
Munich 451
Dong Ket 422
Dublin 407
Andover 283
Nanjing 258
Beijing 249
Izmir 246
Boardman 245
Moscow 217
Salerno 208
Pellezzano 171
Helsinki 152
Düsseldorf 145
Naples 130
Valencia 117
Los Angeles 107
Fairfield 100
Shenyang 90
Nuremberg 88
Nanchang 86
Changsha 84
Jiaxing 80
Hebei 77
São Paulo 68
New York 66
Turku 62
Washington 56
Redwood City 55
Ho Chi Minh City 52
Brooklyn 50
Norwalk 48
Rome 48
Tianjin 46
Vienna 45
Pune 39
Santa Clara 39
Dearborn 37
Brno 36
Napoli 36
Cambridge 34
Seattle 33
The Dalles 33
Council Bluffs 32
Hanoi 30
Rio de Janeiro 30
San Francisco 30
Columbus 29
Tokyo 28
Boston 27
San Diego 27
London 26
Warsaw 25
Chicago 24
Addis Ababa 23
Milan 23
Guangzhou 22
Stockholm 22
Jinan 21
Phoenix 21
Mestre 20
Belo Horizonte 19
Brasília 19
Montreal 19
Seoul 19
Toronto 19
Falls Church 18
Charlotte 17
Chennai 17
Grevenbroich 17
Jyväskylä 17
Ottawa 17
Fisciano 16
Manchester 16
Atlanta 15
Curitiba 15
Amsterdam 14
Johannesburg 14
Lappeenranta 14
Mumbai 13
Porto Alegre 13
Quito 13
Zhengzhou 13
Shanghai 12
Tashkent 12
Mexico City 11
Tappahannock 11
Amman 10
Campinas 10
Caserta 10
Totale 34.900
Salva come PNG Salva come JPEG
Nome #
The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 885
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 863
Computer aided identification of small molecules interfering with the functional interaction of the urokinase receptor with fMLP receptors 813
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 681
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 614
Endocrine disorders during the first year after autologous stem-cell transplant. 569
Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. 568
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples 539
2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 475
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 447
Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia 447
Aplastic anemia: Pathophysiology 439
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 437
67 KDA laminin receptor expression in human G-CSF mobilized CD34(+) peripheral blood stem cells correlates with their mobilization efficiency 434
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 382
Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. 342
Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review 342
Expression and function of the 67kDa laminin receptor in normal and acute leukemia cells 331
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 325
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 323
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 318
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 302
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 284
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 284
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 278
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 263
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 260
A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes 254
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 250
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells 235
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment 229
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 192
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 187
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 187
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo 181
The urokinase-receptor in infectious diseases. 180
CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples 173
Interleukin-2 therapy in relapsed acute myelogenous leukemia. 165
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 165
A backwards evolution in a case of myeloproliferative disease 164
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 161
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 157
Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes. 157
Unresponsiveness to erythropoietin therapy in a case of Blackfan Diamond anemia. 152
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 151
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 150
Bendamustine in combination with rituximab as first line therapy for patients with chronic lymphocytic leukemia (cll): a retrospective real practice italian multicentre study. 147
Role of the urokinase receptor in hematopoietic stem cell transplantation 145
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 143
A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway. 142
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 140
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 140
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 139
Adjuvant treatment of diabetic foot 137
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial 136
67 kDa laminin receptor: structure, function and role in cancer and infection. 133
Continuous alternate-day low dose lenalidomide in combination with low dose prednisone as frontline treatment for octogenarian newly diagnosed multiple myeloma patients 133
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 133
A GITMO randomised trial in steroid refractory acute graft-versus-host disease: 6methylprednisolone with or without anti-thymocyte globulin 132
Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GVHD: preliminary observations. 130
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 130
High dose rHuEPO may induce complete remission in AML-M6 129
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 129
Blockade of intravascular hemolysis in PNH with the terminal complement inhibitor eculizumab unmasks low-level hemolysis potentially occurring through C3 opsonization 127
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 127
The role of FAS-mediated apoptosis in chronic myelogenous leukemia. 126
High frequency of extramedullary relapse in patients transplanted for acute myeloid leukemia. 125
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 124
Expression of the 67 kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation 123
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. 123
Allogeneic transplantation for multiple myeloma 123
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 123
A novel chromosomal abnormality detected in a case of acute myelomonocytic leukemia. 122
Increased expression of the signaling lymphocyte-activation molecule (mSLAM) in patients with paroxysmal nocturnal hemoglobinuria (PNH). 122
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia 120
Two year follow-up of cyclosporin-A in hypoplastic myelodysplastic leukemia. 120
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 120
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 119
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 118
Impact of cytokine gene polymorphisms in myelodysplastic syndromes (MDS) 118
Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients. 117
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion 117
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome. 117
67 KDa laminin receptor (67LR) expression and function in normal and acute myeloid leukemia CD34(+) cells 116
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 116
Effects of leptin and IGF-1 on bone mineral density in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 116
Higher expression of Fas receptor on CD34+ cells of chronic myelogenous leukemia correlates with hematological response to IFN-alfa. 116
Fas-mediated downmodulation of p210 BCR/ABL results in apoptosis of CD34+ cells of chronic myelogenous leukemia. 116
Fluorescent in situ hybridization with a Y probe in the follow up of sex-mismatch transplanted patients 115
Impact of cytokine gene polymorphism in aplastic anemia (AA) 114
Involvement of the urokinase receptor in the cross-talk between hematopoietic stem/progenitor cells and the bone marrow microenvironment. 114
IgH assessment of non-Hodgkin lymphoma cells on FTA cards. 114
All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukaemia followed by ATRA-induced pseudotumour cerebri. 113
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. 112
Imatinib as salvage therapy for patients with refractory cGVHD 112
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey 111
Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. 110
Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. 110
Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond. 110
Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre Study 110
Totale 22.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.477
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.817 0 0 0 11 328 74 266 25 247 36 357 473
2021/20222.072 21 9 15 65 58 61 21 74 309 273 267 899
2022/20233.454 333 179 103 358 477 728 52 354 560 22 176 112
2023/20241.769 182 250 131 101 144 264 75 93 16 68 105 340
2024/20254.744 165 77 63 149 223 610 880 501 672 253 500 651
2025/202615.953 2.517 6.957 6.325 154 0 0 0 0 0 0 0 0
Totale 43.633